Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
12,680 total articles
Netcapital Inc. has acquired the NetNudge AI Agent Platform assets from Codesharp Corporation to expand its AI-powered solutions in private capital markets. The acquisition supports Netcapital's strategy to leverage its regulatory infrastructure and deliver scalable AI-enabled tools and services, including operational intelligence and workflow auto…
Holley Performance Brands announced their participation in the William Blair Growth Stock Conference on June 3, 2026, where senior management will present and hold investor meetings. The company is known for its portfolio of high-performance automotive aftermarket brands.
Editas Medicine, a gene editing company focused on developing transformative in vivo medicines, updated the timing of its presentation at the 2026 Jefferies Global Healthcare Conference to 2:00 p.m. ET on June 4, 2026. The event will be webcast and archived on the company's website.
Opus Genetics, a clinical-stage biopharmaceutical company focused on gene therapies for inherited retinal diseases, granted 698,000 stock options to ten newly hired non-executive employees as inducements to employment, in compliance with Nasdaq listing rules. These options vest over four years with an exercise price equal to the fair market value a…
HealthEquity, Inc., the largest independent HSA custodian in the US, announced a 29% increase in net income to $69.4 million for Q1 ended April 30, 2026, alongside a 7% revenue growth to $354.6 million. The company expanded its share repurchase program by $1 billion and raised its fiscal 2027 financial outlook, projecting revenues between $1.41 bil…
Asure Software expands its strategic partnership with FRPG Restaurant Rewards, a large GPO serving independent restaurants, to enhance distribution and offer comprehensive cloud-based HR, payroll, and workforce management solutions tailored for the independent restaurant sector. This move aims to help independent restaurants manage labor costs, com…
New Era Energy & Digital, Inc. announced a pending settlement agreement that would result in the dismissal of the company's claims in a lawsuit filed by the State of New Mexico. The agreement includes a $1 million payment to the bankruptcy trustee and explicitly denies liability. The company remains focused on developing its large-scale AI data cen…
Emergent BioSolutions Inc. has secured a $64.5 million contract modification from the U.S. Department of Health and Human Services to provide Botulism Antitoxin Heptavalent (BAT®) as part of its ongoing biodefense supply efforts. The contract supports treatment against botulinum neurotoxin exposure and highlights Emergent's role in national health …
Apogee Therapeutics announced that its management will participate in upcoming Jefferies and Goldman Sachs global healthcare conferences in June 2026, highlighting its clinical-stage biotech developments in immunology and inflammation disease treatments. The company focuses on novel biologics targeting atopic dermatitis, asthma, eosinophilic esopha…
Outlook Therapeutics, a biopharmaceutical company developing ophthalmic formulations for retinal diseases, has priced a $5.0 million at-the-market registered direct offering of 8.5 million shares to its largest shareholder, GMS Ventures and Investments. The proceeds will be used for working capital and general corporate purposes. Additionally, the …
Regeneron Pharmaceuticals announced that the World Health Organization's Therapeutics Advisory Group has recommended prioritizing evaluation of maftivimab, a potent antibody component of its Ebola treatment Inmazeb, for investigational use against the current Bundibugyo ebolavirus outbreak in the Democratic Republic of Congo and Uganda. Inmazeb is …
Aclarion, Inc. responded to Echo Lake Capital's unsolicited $4.00 per share acquisition offer, affirming that its Board is committed to evaluating the proposal in shareholders' best interests. The company also initiated a share repurchase program, signaling confidence in its valuation and long-term growth prospects centered on its healthcare techno…
Old National Bancorp has named Shane Print as President of Commercial & Industrial Banking, leveraging his 25 years of financial services experience to drive innovation and growth. Print will lead C&I Banking efforts, including agribusiness and SBA lending, succeeding Kevin Anderson, who will retire at year's end. The appointment aims to strengthen…
Brandywine Realty Trust announced a quarterly dividend of $0.08 per share payable on July 22, 2026, and confirmed the release of its second quarter 2026 earnings on the same day, followed by a conference call on July 23, 2026. The company is a major US real estate investment trust focused mainly on Philadelphia and Austin.
GPGI, Inc., a company traded on the NYSE under ticker GPGI, announced key leadership appointments at its Husky Technologies business. Mohammad Kanaan has been named Chief Financial Officer and Karen Stone Chief Human Resources Officer, bringing extensive global experience to support Husky's growth and cultural transformation initiatives. These move…
Del Taco Restaurants, Inc. introduces a new nationwide "Get A Lot For What You’ve Got" value menu featuring over 10 items starting at just $1, including fan-favorite items and bundled meal deals. This initiative aims to provide affordable, high-quality options that appeal to today’s budget-minded customers without compromising on taste or freshness…
Tevogen Bio Holdings Inc. (Nasdaq: TVGN) announced progress in its strategic acquisition initiatives aimed at complementing its biotechnology and AI businesses. The planned acquisitions, including a contract research organization (CRO), could potentially produce approximately $100 million in combined annual revenue, supporting the company’s goal to…
Altimmune, Inc. announced promising 48-week data from its IMPACT Phase 2b trial demonstrating that pemvidutide, a novel glucagon/GLP-1 dual receptor agonist, significantly reduces triglycerides, cholesterol, weight, waist circumference, and blood pressure in patients with metabolic dysfunction-associated steatohepatitis (MASH). The drug also improv…
Red Cat Holdings announces ramp-up to full-rate production of the Variant 7, a U.S.-designed and built uncrewed surface vessel under its maritime division Blue Ops, aimed at defense and national security missions. The platform leverages U.S.-made components and modular architecture to ensure adaptability and compliance with government standards, al…
Vishay Precision Group, Inc. (NYSE: VPG), a leader in precision measurement and sensing technologies, announced its participation in two investor conferences in June 2026, including the Noble Capital Markets Emerging Growth Virtual Equity Conference and the 16th East Coast IDEAS Conference. The company will webcast its presentations and offer oppor…
Pharming Group N.V. announced that all proposals presented at its 2026 Annual General Meeting were approved by shareholders. Key approvals included appointing KPMG as external auditor, changes to the remuneration policy for non-executive directors, and renewals of authorizations to issue and repurchase shares. The company operates globally in bioph…
Presurance Holdings, Inc., a Michigan-based property and casualty insurance holding company, announced a 1-for-7 reverse stock split effective June 1, 2026. The reverse split reduces outstanding shares from approximately 26.2 million to 3.7 million, aiming to comply with Nasdaq Capital Market continued listing requirements. The company's stock will…
ProMIS Neurosciences, a clinical-stage biotechnology company focusing on therapies for neurodegenerative diseases, will participate in multiple healthcare conferences in June 2026, presenting its EpiSelect platform and lead Alzheimer's disease candidate PMN310. The company plans to report blinded 6-month interim data from its PRECISE-AD Phase 1b tr…
Akari Therapeutics announced that its CEO discussed the acceptance of its first ASCO abstract, which showcased preclinical data demonstrating synergy between their novel ADC candidate AKTX-101 and a KRAS inhibitor in KRAS-driven pancreatic cancer models. The company emphasized the potential of its proprietary PH1 spliceosome-modulating payload plat…
Fabric.AI has engaged global executive search firm Egon Zehnder to lead the search for a senior project management executive, reinforcing its leadership team to oversee its advancing development of MicroLED optical interconnect technology and other fabless semiconductor solutions for AI infrastructure. The move follows key hires and collaborations,…
